Immunity, volume 48, issue 1, pages 19-33
Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
Cristina Gutiérrez-Vázquez
1
,
F Quintana
2, 3
1
2
Publication type: Journal Article
Publication date: 2018-01-16
Infectious Diseases
Immunology
Immunology and Allergy
Abstract
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that is activated by small molecules provided by the diet, microorganisms, metabolism, and pollutants. AhR is expressed by a number of immune cells, and thus AhR signaling provides a molecular pathway that integrates the effects of the environment and metabolism on the immune response. Studies have shown that AhR signaling plays important roles in the immune system in health and disease. As its activity is regulated by small molecules, AhR also constitutes a potential target for therapeutic immunomodulation. In this review we discuss the role of AhR in the regulation of the immune response in the context of autoimmunity, infection, and cancer, as well as the potential opportunities and challenges of developing AhR-targeted therapeutics.
Found
Found
Top-30
Journals
10
20
30
40
50
60
|
|
Frontiers in Immunology
52 publications, 7.61%
|
|
International Journal of Molecular Sciences
46 publications, 6.73%
|
|
Nature Communications
13 publications, 1.9%
|
|
Scientific Reports
12 publications, 1.76%
|
|
Cells
10 publications, 1.46%
|
|
Nutrients
8 publications, 1.17%
|
|
Cancers
7 publications, 1.02%
|
|
Biochemical Pharmacology
7 publications, 1.02%
|
|
Frontiers in Microbiology
6 publications, 0.88%
|
|
Frontiers in Oncology
5 publications, 0.73%
|
|
Nature Immunology
5 publications, 0.73%
|
|
Cell Reports
5 publications, 0.73%
|
|
Nature
5 publications, 0.73%
|
|
PLoS ONE
5 publications, 0.73%
|
|
Proceedings of the National Academy of Sciences of the United States of America
5 publications, 0.73%
|
|
Viruses
4 publications, 0.59%
|
|
Antioxidants
4 publications, 0.59%
|
|
Nature Reviews Immunology
4 publications, 0.59%
|
|
International Immunopharmacology
4 publications, 0.59%
|
|
Chemosphere
4 publications, 0.59%
|
|
Journal of Autoimmunity
4 publications, 0.59%
|
|
Trends in Immunology
3 publications, 0.44%
|
|
Immunity
3 publications, 0.44%
|
|
Molecular Medicine Reports
3 publications, 0.44%
|
|
Journal of Clinical Medicine
3 publications, 0.44%
|
|
Mucosal Immunology
3 publications, 0.44%
|
|
Ageing Research Reviews
3 publications, 0.44%
|
|
Pharmacological Research
3 publications, 0.44%
|
|
Ecotoxicology and Environmental Safety
3 publications, 0.44%
|
|
10
20
30
40
50
60
|
Publishers
20
40
60
80
100
120
140
160
|
|
Elsevier
157 publications, 22.99%
|
|
Springer Nature
112 publications, 16.4%
|
|
MDPI
105 publications, 15.37%
|
|
Frontiers Media S.A.
84 publications, 12.3%
|
|
Wiley
38 publications, 5.56%
|
|
Taylor & Francis
27 publications, 3.95%
|
|
Cold Spring Harbor Laboratory
25 publications, 3.66%
|
|
Oxford University Press
14 publications, 2.05%
|
|
American Chemical Society (ACS)
9 publications, 1.32%
|
|
Ovid Technologies (Wolters Kluwer Health)
6 publications, 0.88%
|
|
Public Library of Science (PLoS)
6 publications, 0.88%
|
|
BMJ
5 publications, 0.73%
|
|
Proceedings of the National Academy of Sciences (PNAS)
5 publications, 0.73%
|
|
Bentham Science Publishers Ltd.
4 publications, 0.59%
|
|
American Society for Microbiology
4 publications, 0.59%
|
|
Hindawi Limited
4 publications, 0.59%
|
|
Royal Society of Chemistry (RSC)
4 publications, 0.59%
|
|
American Association for Cancer Research (AACR)
4 publications, 0.59%
|
|
Spandidos Publications
3 publications, 0.44%
|
|
SAGE
3 publications, 0.44%
|
|
Federation of American Societies for Experimental Biology (FASEB)
3 publications, 0.44%
|
|
American Association for the Advancement of Science (AAAS)
3 publications, 0.44%
|
|
American Physiological Society
3 publications, 0.44%
|
|
eLife Sciences Publications
3 publications, 0.44%
|
|
Annual Reviews
3 publications, 0.44%
|
|
The American Association of Immunologists
2 publications, 0.29%
|
|
American Society for Clinical Investigation
2 publications, 0.29%
|
|
American Society for Pharmacology and Experimental Therapeutics
2 publications, 0.29%
|
|
Mary Ann Liebert
2 publications, 0.29%
|
|
20
40
60
80
100
120
140
160
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Gutiérrez-Vázquez C., Quintana F. Regulation of the Immune Response by the Aryl Hydrocarbon Receptor // Immunity. 2018. Vol. 48. No. 1. pp. 19-33.
GOST all authors (up to 50)
Copy
Gutiérrez-Vázquez C., Quintana F. Regulation of the Immune Response by the Aryl Hydrocarbon Receptor // Immunity. 2018. Vol. 48. No. 1. pp. 19-33.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.immuni.2017.12.012
UR - https://doi.org/10.1016/j.immuni.2017.12.012
TI - Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
T2 - Immunity
AU - Gutiérrez-Vázquez, Cristina
AU - Quintana, F
PY - 2018
DA - 2018/01/16
PB - Elsevier
SP - 19-33
IS - 1
VL - 48
SN - 1074-7613
SN - 1097-4180
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2018_Gutiérrez-Vázquez,
author = {Cristina Gutiérrez-Vázquez and F Quintana},
title = {Regulation of the Immune Response by the Aryl Hydrocarbon Receptor},
journal = {Immunity},
year = {2018},
volume = {48},
publisher = {Elsevier},
month = {jan},
url = {https://doi.org/10.1016/j.immuni.2017.12.012},
number = {1},
pages = {19--33},
doi = {10.1016/j.immuni.2017.12.012}
}
Cite this
MLA
Copy
Gutiérrez-Vázquez, Cristina, et al. “Regulation of the Immune Response by the Aryl Hydrocarbon Receptor.” Immunity, vol. 48, no. 1, Jan. 2018, pp. 19-33. https://doi.org/10.1016/j.immuni.2017.12.012.
Found error?
Found error?